Fig. 2From: Nanomedicine-enabled chemotherapy-based synergetic cancer treatmentsa Schematic representation of active tumor penetration of nanomedicine mediated by cationization-initiated transcytosis. b The structures with or without GGT-responsive cationized drug-conjugated nanomedicine. d The biodistribution of CPT within 24Â h after intravenous administration of different nanomedicinesBack to article page